PRESTO: A Phase 3, Open-Label Study of Androgen Annihilation in Patients with High-Risk, Biochemically Relapsed Prostate Cancer (AFT-19)
- Citation:
- Ann Oncol vol 33 (57) abstr LBA63
- Meeting Instance:
- ESMO 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Funding:
- AFT
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 4065
- Pharmas:
- Janssen
- Grants:
- Corr. Author:
- Authors:
- Rahul Aggarwal Glenn Heller David Hillman Han Xiao Joel Picus Jennifer Wang Mary-Ellen Taplin Tanya Dorff Leonard Appleman Douglas Weckstein Akash Patnaik Alan Bryce Daniel Shevrin James Mohler Daniel Anderson Arpit Rao Scott Tagawa Alan Tan Scott E. Eggener Michael J. Morris
- Networks:
- CA043, CA136, IL018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-NY158, LAPS-PA015, LAPS-TX035, METROMIN, NH038, NY018, TX041
- Study
- AFT-19
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: